Randomized, Controlled, Open-label, Global Multi-center Trial to Assess the Efficacy and Safety of Zipalertinib plus Chemotherapy versus Chemotherapy Alone, in Patients with Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small…
Randomized, Controlled, Open-label, Global Multi-center Trial to Assess the Efficacy and Safety of Zipalertinib plus Chemotherapy versus Chemotherapy Alone, in Patients with Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutation
- Promotore
- Taiho Oncology, Inc
- Acronimo
- REZILIENT3 (TAIHO)
- Struttura
- Oncologia
- Sperimentatore principale
- Zai Silvia
- Stato arruolamento
- In attesa di arruolamento
- Unit di ricerca
- Patologie respiratorie e inquinamento ambientale